BDBM50106546 CHEMBL134546::{6-[3,5-Dihydroxy-2-(3-hydroxy-oct-1-enyl)-cyclopentyl]-hex-4-enyl}-phosphinic acid

SMILES CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCP(O)=O

InChI Key InChIKey=AVGLHCULUVOTRL-FFIXVXCLSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50106546   

TargetThromboxane A2 receptor(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50106546(CHEMBL134546 | {6-[3,5-Dihydroxy-2-(3-hydroxy-oct-...)
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding of the compound at TP human prostaglandin receptor using [3H]-SQ-29,548 as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50106546(CHEMBL134546 | {6-[3,5-Dihydroxy-2-(3-hydroxy-oct-...)
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding of the compound at prostanoid IP receptor using [3H]-Iloprost as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E2 receptor EP1 subtype(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50106546(CHEMBL134546 | {6-[3,5-Dihydroxy-2-(3-hydroxy-oct-...)
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding of the compound at EP1 human prostaglandin receptor using [3H]-PGE-2 as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin F2-alpha receptor(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50106546(CHEMBL134546 | {6-[3,5-Dihydroxy-2-(3-hydroxy-oct-...)
Affinity DataIC50:  114nMAssay Description:In vitro binding of the compound at FP human prostaglandin receptor using [3H]-PGF-2 alpha as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin D2 receptor(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50106546(CHEMBL134546 | {6-[3,5-Dihydroxy-2-(3-hydroxy-oct-...)
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding of the compound at DP human prostaglandin receptor using [3H]- PGD-2 as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50106546(CHEMBL134546 | {6-[3,5-Dihydroxy-2-(3-hydroxy-oct-...)
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding of the compound at EP2 human prostaglandin receptor using [3H]-PGE-2 as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50106546(CHEMBL134546 | {6-[3,5-Dihydroxy-2-(3-hydroxy-oct-...)
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding of the compound at EP4 human prostaglandin receptor using [3H]-PGE-2 as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E2 receptor EP3 subtype(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50106546(CHEMBL134546 | {6-[3,5-Dihydroxy-2-(3-hydroxy-oct-...)
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding of the compound at EP3 human prostaglandin receptor using [3H]-PGE-2 as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed